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 The study of Nucleotide-Binding Oligomerization Domain (NOD) Proteins is a very 
new area of immunology, with the gene for NOD2 having only been mapped in 2001 
(Ogura et al 2001).  It holds particular significance for those researching autoimmune 
disorders such as Blau syndrome and Crohns Disease (CD), as it has been found 
that a mutation in the NOD2 gene is present in a substantial proportion of CD 
sufferers, and having the mutation increases a person‟s susceptibility to developing 
the disease later in life (Economou et al 2004).  This review will look at the current 
research surrounding the NOD proteins and what products they form, and how this 
can be used to further our knowledge of CD and how it can be managed.  It will be 
specifically looking into the effects that NOD proteins in macrophages have on the 
secretion of various pro- and anti-inflammatory cytokines and how these can be 
augmented by the interaction of NOD protein signalling pathways with those of other 
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 To understand the effects of NOD proteins in macrophages, it is important to 
first understand the macrophage and how its subsets can augment effects from 
many different stimuli. 
 Macrophages are specialized cells of the immune system capable of 
phagocytosing exogenous antigens, for example bacterial microorganisms and 
their cellular components; and endogenous matter, such as apoptotic bodies and 
cellular debris.  Originating from myeloid progenitor cells, macrophages have 
several stages of development.  The first stage of this development leads to the 
formation of a Granulocyte-monocyte progenitor cell, which can develop further 
into either a neutrophil or a Monocyte, the precursor to a macrophage (Goldsby 
et al 2003).   When activated, macrophages secrete several different molecules 
known as chemokines or cytokines, depending on their function, including 
interleukin-1β (IL-1β), IL-10, IL-12, IL-8 and TNF-α.  These soluble proteins act 
as chemical messengers, which serve to regulate immune responses to 
antigens, and will be discussed in further detail later. 
 First proposed by Stein et al in 1992, it is now widely accepted that there are 
at least 2 distinct types of macrophage; Classically activated (M1) and 
Alternatively activated (M2), which work together to regulate the immune 
response to pathogens.  Research is currently ongoing into the possibility of 
further subsets of M2 macrophages (Mantovani et al 2004, Gordon 2006, Mosser 
2003).  Synthetic chemical stimulation can be used to differentiate monocytes to 
these different states of activation, as demonstrated in studies by Schwende 
(1996), whose investigation involved the exposure of human monocytic THP-1 
cells to Phorbol-12-myristate-13-acetate (PMA) or 1,25-dihydroxyvitamin D3 
(VD3) to stimulate differentiation to M1 or M2 macrophages respectively.  
Mantovani et al (2004) have recently published supporting evidence that 
monocytes can undergo different forms of activation, resulting in polarized 
macrophages which differ in their response to antigenic stimulation.  They 
propose that this polarization can be induced naturally via stimulation with 
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Interferon-γ (IFN- γ) or Interleukin-10 (IL-10), which form M1 and M2 
macrophages respectively, and that M2 macrophages can also be induced by 
exposure to IL-13 or IL-4.  Conversely, recent theories proposed by S. Gordon 
(2003) hypothesize that IL-10 acts to deactivate M1 macrophages, and M2 
macrophages are only formed when monocytes are exposed to IL-13 or IL-4.  
Both granulocyte-macrophage-colony stimulating factor (GM-CSF) and M-CSF 
have also been implicated in the differentiation of monocytes to M1 and M2 
macrophages respectively (Verrick et al 2004); however more research is 
required into this area before the exact requirements for the various 
differentiation pathways can be stated conclusively.   
 The study by H. Schwende revealed clear differences in the morphology, 
proliferation and phagocytic ability of M1 and M2 macrophages; however it did 
not find accurate differences in the cytokines and chemokines that are released.  
This detail has since been determined and is outlined in Mantovani‟s study 
(2004), which reveals variances in the cytokines, chemokines and effecter 
molecules that are secreted, as well as variances in the membrane cytokine and 
chemokines receptors that are expressed on the surface of the macrophage.  
Mantovani et al demonstrated that M2 macrophages express decreased levels of 
pro-inflammatory cytokines compared with M1 type macrophages, which may be 
explained by the comparatively high expression of scavenger receptors on the 
M2 cell surface.  Scavenger receptors are transmembrane proteins which bind to 
microorganisms to promote phagocytosis and internalization to lysosomal 
compartments within the macrophage, and do not involve any signaling cascades 
(Kaisho and Akira 2006).  These opposing types of macrophage are proposed by 
S. Gordon (2003) to be responsible for the induction of pro- and anti-








Cytokines: Role in immunity 
 
 Cytokines play a very important role in the control and regulation of the 
immune system.  As discussed above, some play a role in the differentiation and 
activation of macrophages, which in turn have an impact on the immune 
response to an invasive pathogen.  However, this ability to active cells of the 
immune system is not limited to the activation of macrophages.  A wide range of 
cytokines are capable of activating and suppressing leukocytes of the innate and 
adaptive immune response, such as antigen-presenting cells, B-cells and T-cells, 
all of which are vital for an effective response to injury or pathogenic challenge.  
Regulation of these cytokines is essential for normal immune function, and their 
uncontrolled expression can lead to the development of immunopathology, such 
as CD or cancer.  Inappropriate secretion of cytokines and expression of cytokine 
receptors can also be responsible for the development of allergies and some 
immunodeficiencies, resulting from an imbalance in the levels of T-helper 1 (Th1)/ 
Th2 cells, which promote a cell mediated or humoral response respectively (Viola, 
Contento and Molon, 2006).   
 There are four families of cytokines; the hematopoietin family, the interferon 
family, the chemokine family and the tumour necrosis family.  The hematopoietin 
family encompasses interleukins such as IL-1β and IL-12 which increase 
inflammation (pro-inflammatory) along with IL-10 and IL-4 which act to decrease 
inflammation (anti-inflammatory).  These cytokines can exert an effect on 
surrounding cells to modulate the immune response; for example, IL-12 
stimulates the differentiation of Th1 cells and induces the production of IFN-γ by 
NK cells, which play a pivotal role in the initial immune response to pathogens 
and are involved in the destruction of cancerous cells.  Although most of the 
hematopoietin family are interleukins, interleukins are not confined solely to the 
hematopoietin family.  IL-8 is a member of the chemokine family, and acts as a 
chemo-attractant, drawing cells of the immune system toward the area of 
infection or injury.  It has a vital role in directing the immune response to the 
appropriate area, and its secretion from macrophages has been linked to NOD2 
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modulated NF-κB activity.  Most pro-inflammatory cytokines are secreted as a 
result of NF-κB dependant gene transcription, while anti-inflammatory cytokines 
such as IL-10 use a different mechanism (Goldsby et al 2003). 
 
NOD proteins: structure and function 
 
 NOD1 and NOD2 (also termed CARD4 and CARD15 respectively) are 
members if the Nod-like receptor family, a group of intracellular proteins which 
detect microbial motifs.  NOD proteins are Pattern Recognition Receptors (PRR), 
which recognise Pathogen Associated Molecular Patterns (PAMP), highly 
conserved regions within microbial components (Chamaillard et al., 2003).  Both 
NOD1 and NOD2 recognise distinct components of peptidoglycan (PGN), which 
is present in all bacterial cell walls, with the exception of the Mycoplasma genus, 
making them very effective intracellular surveillance systems (Philpott and 
Girardin 2004).  NOD1 is present in the cytosol of a wide range of cells, while 
NOD2 is present in the cytosol of myeloid cells, such as neutrophils, dendritic 
cells and, most notably, the macrophage.   NOD2 is also present in astrocytes, 
osteoblasts and the paneth cells of the small intestine, which form part of the 
epithelium, but neither NOD proteins are present in cells of the adaptive immune 
system such as B and T cells (Leung et al 2006).  The expression of NOD2 can 
be up-regulated upon treatment with pro-inflammatory stimuli such as IFN-γ or 
TNFα (Viala, Sansonetti and Philpott 2004).  
 NOD proteins contain a Nucleotide binding site (NBS), leucine rich repeats 
(LRR) and at least one caspase-activating and recruitment domain (CARD) 
(Athman and Philpott 2004).  As shown in figure 1, NOD1 contains one of these 
CARD domains while NOD2 contains two.  Research by Staskawicz et al (2001) 
indicates that binding of the appropriate ligand occurs at the LRR region of the 
NOD protein; however this theory is based on similarities to the structure of TLRs 
and R-proteins in plants, both of which have an LRR binding site, and there is no 
direct experimental evidence to support the LRR as a binding site in NOD 
proteins as yet.    
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 Although both NOD1 and NOD2 detect components of PGN and are 
structurally very similar, the exact motifs they require differ.  The minimal 
naturally occurring PGN structure required for detection by NOD proteins is 
shown is figure 1, and consists of a sugar backbone connected to a peptide 
containing L-Ala-γ-D-Glu (shown in the red and green boxes) which forms the 
molecule muramyl dipeptide (MDP).   
    
 
Figure 1: Showing the minimal structural requirements of PGN for detection by NOD1 and NOD2 (Adapted from Girardin,et al  2003) 
 
 This minimal structure is the same for both NOD1 and NOD2, however NOD1 
requires meso-DAP to be in the terminal position of the peptide (outlined in blue) 
forming the molecule GM-triDAP, in order to detect the molecule as a pathogen, 
while NOD2 detects MDP with either meso-DAP or L-Lys in the terminal position.  
This allows detection of both Gram negative and Gram positive bacteria 
respectively (Girardin et al 2003a).  The mechanism used to internalise the MDP 
into the cell is currently unclear, but research indicates that when the PGN of the 
bacterial cell wall is broken down in the phagolysosome the MDP is exposed, 
which is then detected by NOD2 within the cell, causing a signal cascade which 
culminates with the release of pro and anti-inflammatory cytokines, including IL-
1β, IL-8, IL-10, TNF-α and IL-6 (Strober, W et al 2006).   
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 Abbott et al (2004) were the first to describe the signalling pathway 
downstream of NOD2, and the mechanism by which it activates NF-κB; however, 
although there is speculation as to the pathway by which NOD1 activates NF-κB, 
it has yet to be elucidated.  An overview of the current known processes is shown 
in figure 2.  It has been determined that NOD2 recruits the CARD containing 
serine/threonine kinase RICK (Receptor-activating serine/threonine kinase) 
though CARD-CARD interactions, which then mediates K63-linked 
polyubiquitylation of IκB-kinase-γ (IKKγ), an inhibitor of NF-κB.  The subsequent 
phosphorylation of IKKβ allows the translocation of transcriptional components 
(p50 and p65) to the nucleus.  This initiates the transcription and translation of 
pro-inflammatory cytokine genes. 
 
Figure 2: Showing the possible pathways downstream of NOD1 and NOD2 which lead to the transcription of inflammatory 




 It has been theorized that NOD2 may play a role in the suppression of IL-12 in 
normally functioning cells, based on studies Watanabe et al (2004), who found 
that stimulation of cells expressing mutant NOD2 led to an increase in IL-12 
expression compared with cells expressing wild-type NOD2.  This is supported 
by data from Mannon et al (2004), who found treatment of CD patients with 
antibodies against IL-12 was effective at reducing inflammation of the gut.  Yoo 
et al (2002) showed that NOD1 is able to associate with pro-caspase 1 via 
CARD-CARD interactions, possibly converting the pro-caspase into a caspase 
which can cleave Pro-IL-1β and Pro-IL-18 into the mature forms IL-1β and IL-18. 
Association with pro-caspase is also thought to occur with NOD2 (Damiano et al 
2004), which lends weight to the argument that NOD2 is involved in up-regulation 
of the expression of pro-inflammatory cytokines.   
 In 2001, Girardin et al showed that stimulation of NOD1 led to the activation of 
JUN N-terminal Kinase (JNK), which binds to Activator Protein-1 (AP-1) in the 
nucleus, leading to the transcription of pro-inflammatory genes.  Following this, 
Pauleau and Murray found in 2003 that NOD1 and NOD2 exert an activating 
effect on the mitogen-activated protein kinase (MAPK) pathway.  Their 
experiments showed that activation of NOD2 led to the activation of p38MAPK 
and extracellular-signal-regulated kinase (ERK), and a mutation of NOD2 
eliminated this activating ability.  These pathways can promote cell growth (ERK) 
or apotosis (p38MAPK), and thus a balance between the two must be maintained 
in order to prevent inflammation or uncontrolled apoptotic cell death (Li et al 
2003). 
 
Toll-Like Receptors: Where do they fit in? 
 
 NOD proteins do not exert an appreciable response when stimulated alone.  It 
has been found that simultaneous stimulation of Toll-like receptors is required to 
obtain measurable levels of cytokine secretion (Yang et al 2001).  Toll-like 
receptors (TLRs), so called due to their resemblance to the antifungal Toll 
receptor in the Drosphasila fruit fly, are critical to the response of the innate 
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immune system to microbial infection.  First discovered by Rock et al in 1998, 
there are now descriptions of 10 distinct TLRs.  As shown in figure 3, TLRs I, 2, 
4, 5 and 6 reside on the outer surface of the surface of the cell membrane, while 
TLRs 3, 7, 8 and 9 reside on the inner surface of endosomes within the cell 
(kaisho and Akira 2006).  The exact location and function of TLR 10 has yet to be 
elucidated.  TLRs are PRRs, which directly detect PAMPs in microbial 
components which act as ligands, causing a signal cascade within the cell, 
usually leading to the secretion of cytokines which ultimately leads to Th1 
differentiation.  This has led to research into the possibility of blocking or 
augmenting the function of TLRs in order to change the Th1/ Th2 balance, which 
would open the possibility of managing immune disorders such as allergy, 




Figure 3: Showing the basic structure and position of the TLRs and NOD proteins within the cell (Adapted from Strober et 
al 2006). 
 
 Athman and Philpott (2004) state that TLRs are usually found in high 
proportion in areas of the body that are sterile under normal conditions, and their 
expression is down-regulated in areas that regularly encounter pathogenic 
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challenge, such as the gut, to avoid constitutive activation which would lead to 
chronic inflammation.  This down-regulation could be responsible for the up-
regulated presence of NOD proteins in the intestinal tract in order to maintain a 




TLRs and NOD2: Possible interactions 
 
 It is important to note that TLRs 2 and 4 use a signalling pathway dependant 
on a MyD88 adaptor molecule, a distinctly different pathway to that used by 
either of the NOD proteins (Girardin, Hugot and Sansonetti 2003) 
 Yang et al (2001) used the human monocytic THP-1 cell line to show that 
exposure to MDP alone gives no appreciable cytokine response, which led to 
further investigation into the synergistic effects of LTA or LPS when used in 
conjunction with MDP, to simultaneously activate NOD2 and TLR2 or 4 
respectively.  The study revealed an increased secretion of IL-8, IL-1β and IL-6 
when the cells were exposed to both LPS and MDP compared with controls, and 
a similar result was found when cells were exposed to both LTA and MDP.  This 
indicates that there is an augmentation in the signalling pathways, which leads to 
an increase in transcription of NF-κB.  Evidence supporting these results was 
obtained during similar experiments conducted by Netea et al (2005a) using 
human peripheral mononuclear blood cells and human TLR2 transfected 
Chinese hamster ovary fibroblasts.  In vitro and in vivo studies by Watanabe et al 
(2004) have also indicated the possibility of cross-talk between TLR2 and NOD2, 
which is currently hypothesized to occur due to NOD2 sequestering the RICK 
molecule which would otherwise be involved in the downstream signaling 
pathway of TLR2; however this theory is contradicted by studies showing that 
there is no modulation of TLR4 signaling by NOD2, despite there being evidence 
to show that TLR4 can also signal via the RICK molecule (Strober et al 2006).  
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There is no evidence at present to suggest any interaction between NOD2 with 
TLRs 3, 5, 6, 7, 8 or 9 and NOD proteins, or interaction of NOD1 with any TLRs. 
 
NOD2: Related Immunopathology 
 
 The first description of a mutation in the NOD2 gene linked to Crohns disease 
(CD) was made in 2001 (Hugot et al), and since then there have been more than 
60 variations described, three of which have since been identified as responsible 
for 82% of total NOD2 mutations (R702W, G908R and 3020insC) (Girardin, 
Hugot and Sansonetti 2003).  The 3020insC mutation has since been shown to 
be the most consistent mutation amongst differing population groups (Economou 
et al 2004) and effects the C-terminal third of the NOD2 protein within the LRR 
region, which is thought to be the binding region for MDP.  The product of the 
mutated gene forms a truncated version of NOD2, missing the final 33 amino 
acids which would encode the 10th leucine repeat (Leung et al 2006).  It has been 
observed that this mutation leads to a decrease in transcription of NF-κB in 
response to MDP and as such a decrease in pro-inflammatory cytokine 
expression (Li et al 2004); however CD sufferers maintain increased levels of 
pro-inflammatory cytokines, which results in the chronic inflammation of the gut 
that is characteristic of CD.  This has lead to debate over whether there is a loss 
or gain of function caused by the 3020insC mutation under physiological 
conditions.   
 Supporting the idea of mutation causing a loss of function, Siegmund (2002) 
proposed that one of the main pathogenic mechanisms of CD is an imbalance in 
the Th1/ Th2 polarisation, which is known to lead to allergy and autoimmunity.  
This idea is supported by Watanabe et al (2004), who propose that mutations in 
the NOD2 gene leads to disease by allowing an increase in IL-12 secretion, 
causing an excessive Th1 response, shifting the Th1/ Th2 balance, tending the 
immune system toward a more pro-inflammatory response.  The gain of function 
argument put forward by Maeda et al (2005) suggests that the mutation causes 
the NOD2 to promote processing of Pro-IL-1β, leading to increased secretion of 
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mature IL-1β.  This argument is supported by evidence from investigations using 
inhibitors of IL-1β signalling which showed attenuation in chemically stimulated 
inflammation in mice (Maeda et al 2005). 
 Studies by Leung et al (2006) have investigated the possibility of down-
regulation of NOD2 activity by the presence of alternatively spliced NOD2 
transcript variants, a mechanism found to be used by TLRs, which are 
unresponsive to MDP, but do not antagonise the activity of wild-type NOD2.  This 
method of alternative splicing is employed in TLR4, in which soluble splice 
variants form part of a feedback loop, which prevents uncontrolled TLR4 activity.  
The study also investigated the possibility of restoring mutant NOD2 function by 
the transfection of a “stand-alone” LRR domain into the effected cells, as it has 
been shown possible to restore the function of plant R proteins, with similar 
mutations, by the transfection of missing LRR domain.  The investigation 
revealed that the mutant NOD2 proteins did not have the ability to co-express the 




 Although their function is still not fully understood, it seems that there are 
several factors which combine to determine the effect NOD proteins have on the 
secretion of cytokines from macrophages.  The type of macrophage is important 
as it ultimately determines whether the immune response to the invading 
pathogen is to be pro- or anti-inflammatory by its interaction with other cells of 
the immune system.  The type of TLR ligand is also important, as current 
research indicates that there is only interaction between the signalling pathways 
of NOD2 with TLRs 2 and 4, and as such only lipid ligands would be expected to 
produce a synergistic or suppressive effect in conjunction with NOD2.   
 There are several lines of research still underway to determine the exact 
mechanisms by which NOD proteins function, for example in 2005 Barnich et al 
showed that NOD2 was capable of associating with the cell surface membrane of 
intestinal epithelial cells, and proposed that this membrane targeting was 
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necessary for NF-κB activation via MDP stimulation, as the cell membrane 
association was not observed in cells expressing the NOD2 3020insC mutant. 
This would support a loss of function hypothesis; however this data has yet to be 
substantiated by independent studies.  Studies by Netea et al (2005b) have 
indicated that there is cross-talk between the NOD1 and NOD2 signalling 
pathways, having observed a decreased response to the NOD1 ligand GM-
triDAP and gram-negative PGN when the cell is homozygous for the mutant 
3020insC NOD2 gene.  This effect was only observed when this specific 
mutation is present, and did not occur when any other NOD2 gene mutation is 
induced; indicating that a decreased NOD1 function may also contribute to the 
severity of CD, however again this data has not yet been confirmed by 
independent studies. 
 Previous research has revealed many challenges to the investigation of the 
function of NOD proteins in humans.  Murine macrophages are widely used a 
model for human cells, but some reports indicate that murine macrophages react 
differently compared with human THP-1 cells with identical treatments (Pauleau 
and Murray 2003).  The transfection of NOD2 into other cell types can be 
unreliable, as they contain the apparatus for distinctly different signaling 
pathways to that found in the human macrophage.  Human peripheral blood 
mononuclear cells have also been used, which include several cell types that do 
not have the NOD2 protein, but may have other methods of detecting MDP.  
Research now needs to be focused on the use of human macrophages, such as 
the human monocytic cell line THP-1 in order to reduce the error introduced into 
experiments by the use of alternative cell types. 
 
Further studies required  
 
 Determination of the role NOD1 and NOD2 play in the activation or 
suppression of the MAPK pathways could reveal a role for NOD proteins in cell 
growth or apoptosis, and the clarification of the cytokines which are directly 
affected by NOD proteins would greatly increase understanding of the role of 
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NOD proteins in normal immune function and in disease states.  The theory that 
NOD2 is able to affect the function of IL-1β Converting Enzyme (ICE, Caspase-1) 
may also link to increased apoptosis of macrophages, as high levels of IL-1β 
secretion are usually observed only when the macrophage is induced to undergo 
apoptosis (Hogquist et al 1991).  Further study of the interaction of NOD2 with 
ICE could lead to possible treatments targeting ICE and the production of the 
pro-inflammatory cytokines IL-1β and IL-18 to reduce the inflammation 
characteristic of IBD.  Investigation into the use of antibiotics to determine the 
contribution of commensual bacteria as a stimulus for the initiation and 
continuation of IBD would be of great interest, and could be studied in 
conjunction with NOD2 gene variants to determine any relationship between 
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